Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy

Molecular Medicine Reports
Tianbo JinLongli Kang

Abstract

Cytochrome P450 2C19 (CYP2C19) is a highly polymorphic gene, it codes for a protein responsible for the metabolism of multiple clinically important therapeutic agents. However, there is currently no available data on the distribution of CYP2C19 mutant alleles in the Tibetan population. The aim of the present study was to identify different CYP2C19 mutant alleles and determine their frequencies, along with genotypic frequencies, in the Tibetan population. The whole CYP2C19 gene was amplified and sequenced in 96 unrelated, healthy Tibetans from the Tibet Autonomous Region of China, the promoter region, exons, introns and the 3'‑UTR were screened for genetic variants. Three novel genetic polymorphisms in CYP2C19 were detected among a total of 27 different mutations. The allele frequencies of CYP2C19*1A, *1B, *2A, *3A and *17 were 50, 28.13, 15.10, 5.21 and 1.56%, respectively. The most common genotype combinations were CYP2C19*1A/*1B (56.25%) and *1A/*2A (30.21%). One novel non‑synonymous mutation (Asn to Lys) in CYP2C19 was identified, and this mutation was predicted to be intolerant and benign by SIFT and PolyPhen‑2, respectively. The observations of the present study may have important clinical implications for the use of medic...Continue Reading

References

Jun 1, 1995·Clinical Pharmacology and Therapeutics·C MasimirembwaM Ingelman-Sundberg
Nov 1, 1996·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S OnoT Satoh
Dec 1, 1996·Pharmacogenetics·I PerssonM Ingelman-Sundberg
Jun 19, 1998·Therapeutic Drug Monitoring·M KimuraS Higuchi
Nov 23, 2000·Lancet·U A Meyer
Oct 27, 2001·British Journal of Clinical Pharmacology·J A Goldstein
Nov 1, 2001·Journal of Gastroenterology·S YamadaN Matsukura
Mar 5, 2002·Genome Research·Pauline C Ng, Steven Henikoff
Apr 17, 2002·European Journal of Clinical Pharmacology·Nan HeHong-Hao Zhou
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Jul 25, 2003·European Journal of Clinical Pharmacology·Elena A GaikovitchIvar Roots
Jun 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maria Gabriella ScordoEdoardo Spina
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Mar 19, 2005·European Journal of Clinical Pharmacology·Heydy V Bravo-VillaltaRyuya Horiuchi
Jul 19, 2005·European Journal of Clinical Pharmacology·Jónrit HallingKim Brøsen
Jul 11, 2006·Annual Review of Genomics and Human Genetics·Pauline C Ng, Steven Henikoff
Sep 14, 2006·Pharmacological Reviews·Sharon J Gardiner, Evan J Begg
Dec 12, 2007·British Journal of Clinical Pharmacology·László KóboriKatalin Monostory
Sep 16, 2011·Journal of Clinical Pharmacy and Therapeutics·D AnichavezhiC Adithan

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Haploview
SIFT
PolyPhen
Sequencher

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.